NeuroMetrix, Inc. (NURO)
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
$7.74M
Dr. Shai N. Gozani M.D., Ph.D.
23.00
Woburn, MA
Jul 22, 2004
-0.70
$-5.44
1.01
11.62
-181.03%
-0.96
-0.03
0.44
1.77
10.71
-41.92%
-41.73%
Similar stocks (12)
OpGen, Inc.
OPGN
Vivos Therapeutics, Inc.
VVOS
ReShape Lifesciences Inc.
RSLS
Talis Biomedical Corporation
TLIS
Bone Biologics Corporation
BBLG
Heart Test Laboratories, Inc.
HSCS
Sintx Technologies, Inc.
SINT
ThermoGenesis Holdings, Inc.
THMO
Bluejay Diagnostics, Inc.
BJDX
Nuwellis, Inc.
NUWE
NanoVibronix, Inc.
NAOV
Tivic Health Systems, Inc.
TIVC
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (12)
OpGen, Inc.
OPGN
Vivos Therapeutics, Inc.
VVOS
ReShape Lifesciences Inc.
RSLS
Talis Biomedical Corporation
TLIS
Bone Biologics Corporation
BBLG
Heart Test Laboratories, Inc.
HSCS
Sintx Technologies, Inc.
SINT
ThermoGenesis Holdings, Inc.
THMO
Bluejay Diagnostics, Inc.
BJDX
Nuwellis, Inc.
NUWE
NanoVibronix, Inc.
NAOV
Tivic Health Systems, Inc.
TIVC
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%